Amylyx Pharmaceuticals Inc AMLX Valuation Ratios and Share Stats

S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Amylyx Pharmaceuticals Inc (AMLX)
Amylyx Pharmaceuticals Inc (AMLX) Financials

Amylyx Pharmaceuticals Inc (AMLX)

5.66

0.39

(7.40%)

Closed November 25 3:00PM

Delayed by 15 minutes

5.66

0.00

( 0.00% )

Pre Market: 3:50AM

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End December 30 2023	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-851.925	-158.347	-146.897	-79.818	10.842
Return on Equity (%)	108.183	29.791	80.71	-209.434	12.731
Return on Invested Capital (%)	978.982	-1076.996	-177.29	-94.574	9.282
Operating Margin (%)	-872.37	-872.37	-30852.982	-888.893	14.259
Net Profit Margin (%)	-961.851	-961.851	-30852.982	-892.375	12.939
Book Value Per Share	-2.95	0.89	3.171	3.902	4.908
Earnings Per Share	-2.288	-2.288	-3.162	-2.272	0.558
Cash Per Share	0.511	2.148	1.805	0.716	1.927
Working Capital Per Share	-0.221	1.053	3.149	3.843	4.333
Operating Profit Per Share	0.238	0.238	0.01	0.226	4.036
EBIT Per Share	-2.288	-2.288	-3.162	-2.263	0.615
EBITDA Per Share	-2.288	-2.288	-3.162	-2.263	0.615
Free Cash Flow Per Share	-2.288	-2.288	-3.151	-2.249	0.56

Liquidity Ratios

Year End December 30 2023	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	5.99M	5.99M	7.02M	66.51M	N/A

Key Stats and Ratios

Year End December 30 2023	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	N/A	66.51M	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	1.964	N/A	N/A	N/A	-133.74	N/A
Net Profit Margin (%)	N/A	N/A	2.202	N/A	N/A	N/A	-134.013	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	387.98M
Price to Earnings Ratio	7.87
Price to Sales Ratio	1.02
Price to Cash Ratio	2.28
Price to Book Ratio	0.9
Dividend Yield	-

Share Statistics

Shares Outstanding	68.55M
Average Volume (1 week)	1.26M
Average Volume (1 Month)	1.54M
52 Week Change	-56.56%
52 Week High	19.9488
52 Week Low	1.575

More Ratios Coming Soon!

Amylyx Pharmaceuticals

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions